The emerging challenge of optimal blood pressure management and hypertensive syndromes in pregnant women with sickle cell disease: a review

References

• Dare FO, Makinde OO, Faasuba OB. The obstetric performance of sickle cell disease patients and homozygous hemoglobin C disease patients in Ile-Ife, Nigeria. Int J Gynecol Obstet. 1992;37(37):163–168.
   PubMed Web of Science ®Google Scholar
• Stamilio DM, Sedhev HM, Macones GA. Pregnant women with the sickle cell trait are not at increased risk for developing preeclampsia. Amer J Perinatol. 2003;20(01):041–048.
   PubMed Web of Science ®Google Scholar
• Carlin A, Alfirevic Z. Physiological changes of pregnancy and monitoring. Best Pract Res Clin Obstet Gynecol. 2008;22(5):801–823.
   PubMed Web of Science ®Google Scholar
• Pegelow CH, Colangelo L, Steinberg M, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Amer J Med. 1997;102(2):171–177.
   PubMed Web of Science ®Google Scholar
• Oguanobi NI, Onwubere BJ, Ibegbulam OG, et al. Arterial blood pressure in adult Nigerians with sickle cell anemia. J Cardiol. 2010;56(3):326–331.
   PubMed Web of Science ®Google Scholar
• De Jong PE, Landman H, van Eps LWS. Blood pressure in sickle cell disease. Arch Int Med. 1982;142(6):1239–1240.
   PubMedGoogle Scholar
• Adams-Campbell LL, Nwankwo MU, Ukoil FA, et al. The sickle gene: a marker for blood pressure? J Natl Med Assoc. 1993;85(5):385–387.
   PubMed Web of Science ®Google Scholar
• Johnson CS, Giorgio AJ. Arterial blood pressure in adults with sickle cell disease. Arch Intern Med. 1981;141(7):891–893.
   PubMed Web of Science ®Google Scholar
• Green-top Guideline No. 61. Management of sickle cell disease in pregnancy. Royal College of Obstetricians and Gynaecologists; 2011.
   Google Scholar
• National Heart Lung and Blood Institute: Division of Blood Diseases and Resources. Management of Sickle Cell Disease. NIH Publication 04-2117, 2002. Revised in 2004. Available from: http://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pdf
   Google Scholar
• Thame M, Lewis J, Trotman H, et al. The mechanisms of low birth weight in infants of mothers with homozygous sickle cell disease. Pediatr. 2007;120(3):e686–e693.
   PubMed Web of Science ®Google Scholar
• Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The framingham heart study. Circ. 2001;103(9):1245–1249.
   PubMed Web of Science ®Google Scholar
• Villers MS, Jamison MG, De Castro LM, et al. Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol. 2008;199(2):125.e121-125.e125.
   PubMed Web of Science ®Google Scholar
• Wilson M, Morganti AA, Zervoudakis I, et al. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med. 1980;68(1):97–104.
   PubMed Web of Science ®Google Scholar
• Kotchen T. Historical trends and milestones in hypertension research: a model of the process of translational research. Hypertens. 2011;58(4):522–538.
   PubMed Web of Science ®Google Scholar
• Moise N, Tzonk K, Goldman L. From JNC 1 to JNC 8: populations impact and cost-effectiveness of U.S. hypertension guidelines. Circ. 2015;131(Suppl 1):A24–A24.
   Google Scholar
• Singh R. Hypertensive disorders in pregnancy. Clin Queries: Nephrol. 2013;2(2):47–55.
   Google Scholar
• Chames MC, Haddad B, Barton JR, et al. Subsequent pregnancy outcome in women with a history of HELLP syndrome at ≤ 28 weeks of gestation. Am J Obstet Gynecol. 2003;188(6):1504–1508.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Treatment of hypertension in pregnant women. Nejm. 1996;335(4):257–265.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Ramadan MK, Chari RS, et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol. 1995;172(1, Part 1):125–129.
   PubMed Web of Science ®Google Scholar
• Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(7):575–576.
   Google Scholar
• Mj B. A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs. 2010;39(5):510–518.
   PubMed Web of Science ®Google Scholar
• Sep S, Verbeek J, Koek G, et al. Clinical differences between early-onset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum. Am J Obstet Gynecol. 2010;202(3):271.e271-271.e275.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Eclampsia. Am J Obstet Gynecol. 1990;163(3):1049–1054.
   PubMed Web of Science ®Google Scholar
• Mattar F, Sibai BM, Eclampsia VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol. 2000;182(2):307–312.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DK, Ojea AM, et al. Blood pressure patterns in normal pregnancy, gestational hypertension, and preeclampsia. Hypertens. 2000;36(2):149–158.
   PubMed Web of Science ®Google Scholar
• Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract & Res Clin Obstet& Gynecol. 2011;25(4):391–403.
   PubMed Web of Science ®Google Scholar
• Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obst Gynecol. 1990;162(2):311–316.
   PubMed Web of Science ®Google Scholar
• Martin JN Jr, Blake PG, Perry KG Jr, et al. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obst Gynecol. 1991;164(6):1500–1513.
   PubMed Web of Science ®Google Scholar
• Smith JA, Espeland M, Bellevue R, et al. Pregnancy in sickle cell disease: experience of the cooperative study of sickle cell disease. Obst & Gynecol. 1996;87(2):199–204.
   PubMed Web of Science ®Google Scholar
• Habli M, Eftekhari N, Wiebracht E, et al. Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Am J Obst Gynecol. 2009;201(4):381–385.
   PubMed Web of Science ®Google Scholar
• Thornburg KL, Jacobson SL, Giraud GD, et al. Hemodynamic changes in pregnancy. Semin Perinatol. 2000;24(1):11–14.
   PubMed Web of Science ®Google Scholar
• Parrish MR, Morrison JC. Sickle cell crisis and pregnancy. Semin Perinatol. 2013;37(4):274–279.
   PubMed Web of Science ®Google Scholar
• Chakravarty EF, Khanna D, Chung L. Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. Obstet and Gynecol. 2008;111(4):927–934.
   PubMed Web of Science ®Google Scholar
• Rogers DT, Molokie R. Sickle cell disease in pregnancy. Obstet and GynecolClin N Am. 2010;37(2):223–237.
   PubMed Web of Science ®Google Scholar
• Resende Cardoso PS, Lopes Pessoa de Aguiar RA, Marcos Borato V et al. Clinical complications in pregnant women with sickle cell disease: prospective study of factors predicting maternal death or near miss. RevistaBrasileira de Hematologia e Hemoterapia. 2014;36(4):256–263.
   PubMedGoogle Scholar
• Boafor TK, Olayemi E, Galadanci N, et al. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis. BJOG: Int J Obst& Gynecol. 2016;123(5):691–698.
   PubMed Web of Science ®Google Scholar
• Al Kahtani MA, AlQahtani M, Alshebaily MM, et al. Morbidity and pregnancy outcomes associated with sickle cell anemia among Saudi women. Int J Gynecol&Obst. 2012;119(3):224–226.
   PubMed Web of Science ®Google Scholar
• Roberge S, Odibo AO, Bujold E. Aspirin for the prevention of preeclampsia and intrauterine growth restriction. Clin Lab Med. 2016;36(2):319–329.
   PubMed Web of Science ®Google Scholar
• Roberge S, Sibai B, McCaw-Binns A, et al. Low-dose aspirin in early gestation for prevention of preeclampsia and small-for-gestational-age neonates: meta-analysis of large randomized trials. Am J Perinatol. 2016;33(8):781–785.
   PubMed Web of Science ®Google Scholar
• Bergeron TS, Roberge S, Carpentier C, et al. Prevention of preeclampsia with aspirin in multiple gestations: a systematic review and meta-analysis. Am J Perinatol. 2016;33(6):605–610.
   PubMed Web of Science ®Google Scholar
• Roberge S, Giguère Y, Villa P, et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol. 2012;29(7):551–556.
   PubMed Web of Science ®Google Scholar
• Dodd JM, McLeod A, Windrim RC, et al. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Systematic Rev. 2013;(7):CD006780. doi: 10.1002/14651858.CD006780.pub3.
   Web of Science ®Google Scholar
• van den Broek N. Anaemia in pregnancy in developing countries. BJOG: Int J ObstetGynecol. 1998;105(4):385–390.
   Google Scholar
• Oteng-Ntim E, Meeks D, Seed PT, et al. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood. 2015;125:3316–3325.
   PubMed Web of Science ®Google Scholar
• Muganyizi PS, Kidanto H. Sickle cell disease in pregnancy: trend and pregnancy outcomes at a tertiary hospital in Tanzania. PLoS ONE. 2013;8(2):e56541.
   PubMed Web of Science ®Google Scholar
• Sun PS, Wilburn W, Raynor BD, et al. Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. Am J Obstet Gynecol. 2001;184(6):1127–1130.
   PubMed Web of Science ®Google Scholar
• Barfield WD, Barradas DT, Manning SE, et al. Sickle cell disease and pregnancy outcomes: women of african descent. Am J Prev Med. 2010;38(Suppl 4):S542–S549.
   Web of Science ®Google Scholar
• Seely EW, Ecker J. Chronic hypertension in pregnancy. N Engl J Med. 2011;365(5):439–446.
   PubMed Web of Science ®Google Scholar
• Afolabi BB, Iwuala NC, Iwuala IC, et al. Morbidity and mortality in sickle cell pregnancies in Lagos, Nigeria: a case control study. J Obstet Gynecol. 2009;29(2):104–106.
   PubMedGoogle Scholar
• Thame MM, Osmond C, Serjeant GR. Fetal growth in women with homozygous sickle cell disease: an observational study. Eur J Obstet & Gynecol Reprod Biol. 2013;170(1):62–66.
   PubMed Web of Science ®Google Scholar
• Rajab KE, Issa AA, Mohammed AM, et al. Sickle cell disease and pregnancy in Bahrain. Int J Gynecol& Obstet. 2006;93(2):171–175.
   PubMed Web of Science ®Google Scholar
• Serjeant GR, Loy LL, Crowther M, et al. Outcome of pregnancy in homozygous sickle cell disease. Obstet & Gynecol. 2004;103:6.
   PubMed Web of Science ®Google Scholar